Home >> Signaling Pathways >> Tyrosine Kinase

Tyrosine Kinase(酪氨酸激酶)

  1. Cat.No. 产品名称 Information
  2. GC12370 IKK-16 (hydrochloride)

    IKK Inhibitor VII

    IKK-16 (hydrochloride)是一种新型的、具有口服活性的选择性IκB激酶(IKK)抑制剂,IKK-16作用于IKK-2、IKK复合物和IKK-1的IC50值分别为40nM、70nM和200nM
  3. GC17925 PKR-IN-C16

    C16,GW 506033X,Protein Kinase RNA-activated

    PKR-IN-C16是一种靶向ATP结合位点的小分子化合物,能够抑制RNA依赖性蛋白激酶(PKR)的自磷酸化,IC50值为0.21±0.04μM。
  4. GC14054 SR 0987 An agonist of RORγt
  5. GC10408 2-D08 2-D08是一种合成黄酮和具有细胞通透性的小泛素样修饰蛋白(SUMO)抑制剂,也能抑制Axl靶点,IC50为0.49nM。
  6. GC12818 4-methyl Erlotinib

    埃罗替尼杂质G

    A methylated analog of erlotinib
  7. GC10706 Rp-8-pCPT-Cyclic GMPS (sodium salt)

    Rp-8-pCPT-cGMPS

    A competitive inhibitor of cGK isoforms
  8. GC10517 Rp-8-bromo-Cyclic GMPS (sodium salt)

    Rp-8-bromo-cGMPS

    A competitive inhibitor of cGK
  9. GC15145 CEP-28122 An orally active ALK inhibitor
  10. GC15314 PD 166326 An inhibitor of c-src and certain receptor tyrosine kinases, including c-abl
  11. GC10938 AAL-993

    VEGFR Tyrosine Kinase Inhibitor VI,ZK 260253

    Inhibitor of VEGFR1, 2, and 3
  12. GC13905 GSK2981278 An inverse agonist of RORγ
  13. GC14544 JNJ-10198409

    3-氟-N-(6,7-二甲氧基-2,4-二氢茚并[1,2-C〕吡唑-3-基)苯基胺

    A potent PDGF tyrosine kinase inhibitor
  14. GC10644 Neoruscogenin

    新鲁斯可皂苷元

    A bioavailable agonist of RORα
  15. GC14418 SR 1555 (hydrochloride) inverse agonist of RORγ
  16. GC15280 Tivozanib (hydrate)

    AV-951,KRN 951

    A VEGFR inhibitor
  17. GC16483 MAZ51 MAZ51是一种选择性血管内皮生长因子受体3(VEGFR-3;FLT4)酪氨酸激酶抑制剂。
  18. GC11312 EGFR Inhibitor

    Epidermal Growth Factor Receptor Inhibitor

    A selective antagonist of the EGFR
  19. GC14856 EGFR/ErbB2 Inhibitor A dual inhibitor of EGFR and ErbB2
  20. GC13961 ISCK03

    STEM-CELLFACTOR/C-KIT抑制剂 ,c-Kit Inhibitor II,Stem-Cell Factor/c-Kit Inhibitor

    An inhibitor of SCF/c-kit signaling
  21. GC14103 NSC228155 An EGFR activator and inhibitor of KID-KIX interactions
  22. GC15370 Olmutinib (HM61713, BI 1482694)

    奥莫替尼

    An inhibitor of mutant EGFR
  23. GC12712 NT157 NT157是一种具有选择性的胰岛素受体底物-1/-2(IRS-1/2)抑制剂。
  24. GC11726 BAW2881 (NVP-BAW2881)

    BAW2881

    A VEGFR inhibitor
  25. GC15340 BFH772 An inhibitor of VEGFR2
  26. GC15655 AMG 337 A selective c-Met inhibitor
  27. GC15282 LOXO-101 (Larotrectinib) sulfate

    (3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐,LOXO-101 sulfate; ARRY-470 sulfate

    LOXO-101 (Larotrectinib) sulfate是一种口服可用的ATP竞争性泛TRK抑制剂,对TRKA和TRKC的IC50值分别为0.9nM和2.8nM。
  28. GC11321 PRT-060318

    PRT318

    A potent and selective Syk inhibitor
  29. GC15466 RO9021 RO9021 是一种具有口服生物利用度的新型 ATP 竞争性 SYK 抑制剂,平均 IC50 为 5.6 nM。
  30. GC12038 RG 13022

    Tyrphostin RG13022

    An inhibitor of EGF receptor kinase
  31. GC14582 SU5614

    (3Z)-5-氯-3-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-1,3-二氢-2H-吲哚-2-酮

    A multi-kinase inhibitor
  32. GC12281 EAI045 A potent inhibitor of mutant EGFRs
  33. GC10607 GNF-7 A multi-kinase inhibitor
  34. GC17294 CHMFL-ABL-053 CHMFL-ABL-053 (Compound 18a) 是一种有效的、选择性的、可口服的 BCR-ABL、SRC 和 p38 激酶抑制剂,对 ABL1、SRC 和 p38 的 IC50 值分别为 70、90 和 62 nM。
  35. GC14488 NPS-1034

    2-(4-氟苯基)-N-[3-氟-4-[(3-苯基-1H-吡咯并[2,3-B]吡啶-4-基)氧基]苯基]-2,3-二氢-1,5-二甲基-3-氧代-1H-吡唑-4-甲酰胺

    A dual MET/AXL inhibitor
  36. GC13143 AZD3759

    AZD3759

    A brain penetrant inhibitor of EGFR
  37. GC10165 Dovitinib (TKI258) Lactate Hydrate

    多韦替尼,TKI258 lactate hydrate; CHIR-258 lactate hydrate

    A multi-kinase inhibitor

  38. GC14218 TP-0903

    TP-0903

    An Axl kinase inhibitor
  39. GC17790 CL-387785 (EKI-785)

    EKI-785; WAY-EKI 785

    An irreversible inhibitor of EGFR kinase activity
  40. GC16321 EGF816

    那扎替尼; EGF816

    An inhibitor of mutant EGFR
  41. GC10355 Fruquintinib(HMPL-013)

    呋喹替尼; HMPL-013

    An inhibitor of VEGF1, -2, and -3
  42. GC17772 BMS-817378

    [3-[[4-((2-氨基-3-氯吡啶-4-基)氧基)-3-氟苯基]氨基甲酰基]-5-(4-氟苯基)-4-氧代-4H-吡啶-1-基]甲基磷酸二氢酯

    Potent ATP competitive inhibitor of Met/VEGFR2
  43. GC14476 Entrectinib

    恩曲替尼; NMS-E628; RXDX-101

    Entrectinib是一种具有口服活性、可穿透血脑屏障(BBB)且在中枢神经系统起作用的TrkA/B/C、ROS1与ALK抑制剂,其IC50值分别为1、3、5、12和7nM。
  44. GC12222 Pexidartinib (PLX3397)

    培西达替尼,PLX-3397

    Pexidartinib(PLX3397) 是一种口服小分子酪氨酸激酶抑制剂,对集落刺激因子 1(CSF1) 受体 (IC50=20nM)、KIT 原癌基因受体酪氨酸激酶 (KIT)(IC50 = 10nM) 和类 FMS 酪氨酸激酶 3Pexidartinib 在体外是一种比伊马替尼更强的 KIT 抑制剂。
  45. GC11140 Radotinib(IY-5511)

    拉多替尼

    A selective Bcr-Abl tyrosine kinase inhibitor
  46. GC17637 CTX0294885 A broad spectrum kinase inhibitor used in proteomics
  47. GC17669 AMG-47A

    4-甲基-3-[2-[[2-(4-吗啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺

    A multi-kinase inhibitor
  48. GC17500 SU6656 SU6656是一种小分子吲哚酮类化合物,可选择性抑制Src、Yes和Fyn激酶活性,IC50值分别为0.28μM、0.02μM和0.17μM。
  49. GC12955 AZ5104

    奥西替尼中间体

    An active metabolite of AZD 9291
  50. GC17959 AZD2932 A multi-kinase inhibitor
  51. GC16604 Altiratinib

    DCC-2701

    A multiple kinase inhibitor

Items 1001 to 1050 of 1402 total

per page

Set Descending Direction